|Videos|August 27, 2021
IVGE process and optimization
Author(s)Roche
Advertisement
In vitro glycoengineering (IVGE) works by modifying glycosylation enzymatically after proteins are harvested. A specific sugar is linked to a compatible N-glycan backbone in a straightforward and scalable cell-free enzyme reaction. IVGE therefore separates terminal glycosylation from depending on cellular function during fermentation. Watch to learn more about the process and optimization of IVGE reactions.
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Advertisement
Advertisement
Advertisement
Trending on BioPharm International
1
How CDMO Alliances Can Provide End-to-End Service that Reduces Drug Development Time and Costs
2
FDA Clears PharmaResearch IND for Nano-Based Cancer Drug PRD-101
3
First-in-Human Study Validates Safety of Next-Generation mRNA–LNP Platform
4
Industry Outlook 2026: Key Forces Transforming Drug Pipelines (Part 2)
5
